Wnt inhibitory factor 1 ameliorated diabetic retinopathy through the AMPK/mTOR pathway-mediated mitochondrial function.

Zou, Jing; Tan, Wei; Liu, Kangcheng; Chen, Bolin; Duan, TianQi; Xu, Huizhuo

Zou, Jing; Tan, Wei; Liu, Kangcheng; Chen, Bolin; Duan, TianQi; Xu, Huizhuo.

Afiliación

Zou J; Eye Center of Xiangya Hospital, Central South University, Changsha, P.R. China.
Tan W; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, P.R. China.
Liu K; Eye Center of Xiangya Hospital, Central South University, Changsha, P.R. China.
Chen B; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, P.R. China.
Duan T; Eye Center of Xiangya Hospital, Central South University, Changsha, P.R. China.
Xu H; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, P.R. China.

FASEB J ; 36(10): e22531, 2022 10.

Article en En | MEDLINE | ID: mdl-36063130

Asunto(s)

Diabetes Mellitus Experimental; Retinopatía Diabética; Proteínas Quinasas Activadas por AMP/metabolismo; Animales; Diabetes Mellitus Experimental/complicaciones; Diabetes Mellitus Experimental/metabolismo; Retinopatía Diabética/metabolismo; Humanos; Ratones; Mitocondrias/metabolismo; Epitelio Pigmentado de la Retina/metabolismo; Serina-Treonina Quinasas TOR/metabolismo

Palabras clave

AMPK/mTOR pathway; angiogenesis; diabetic retinopathy; mitochondrial dysfunction; wnt inhibitory factor 1

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Experimental / Retinopatía Diabética Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: FASEB J Asunto de la revista: BIOLOGIA / FISIOLOGIA Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google